These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38766983)

  • 1. Safety and infectious outcomes in pediatric kidney transplant recipients after COVID-19 vaccination: A pediatric nephrology research consortium study.
    Churilla T; Crane C; Sreedharan R; Alzarka BJ; Charnaya O; Jain NG; Pizzo H; Mansuri A; Jain A; Grewal M; Fishbein JD; Kula AJ; Heald-Sargent T; Matossian D; Verghese PS
    Pediatr Transplant; 2024 Jun; 28(4):e14786. PubMed ID: 38766983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between PIRCHE-II scores and de novo allosensitization after reduction of immunosuppression during SARS-CoV-2 infection in kidney transplant recipients.
    Castrezana-Lopez K; Malchow R; Nilsson J; Kokkonen SM; Rho E; von Moos S; Mueller TF; Schachtner T
    Transpl Infect Dis; 2023 Apr; 25(2):e14052. PubMed ID: 36884207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination.
    Al Jurdi A; Gassen RB; Borges TJ; Solhjou Z; Hullekes FE; Lape IT; Efe O; Alghamdi A; Patel P; Choi JY; Mohammed MT; Bohan B; Pattanayak V; Rosales I; Cravedi P; Kotton CN; Azzi JR; Riella LV
    Front Immunol; 2022; 13():838985. PubMed ID: 35281011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients.
    McCune TR; Bray RA; Baran DA; Toepp AJ; Forte SJ; Gilgannon LT; Williams T; Chen S; Sadr H; Gebel HM; Herre JM
    Transpl Immunol; 2022 Dec; 75():101722. PubMed ID: 36152939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter- and intra-individual differences regarding SARS-CoV-2 and influenza vaccination in pediatric kidney transplant recipients: An observational study.
    Kanai T; Ito T; Saito T; Aoyagi J; Kurosaki M; Betsui H; Maru T; Ono M; Tajima T
    Medicine (Baltimore); 2024 Jul; 103(27):e38809. PubMed ID: 38968522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-directed immunologic safety of COVID-19 vaccination in renal transplant recipients.
    Kueht M; Kirk K; Scott Lea A; Stevenson HL; Fair J; Kathleen Gamilla-Crudo A; Hussain S; Mujtaba M
    Hum Immunol; 2022; 83(8-9):607-612. PubMed ID: 35871882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children.
    Gulmez R; Ozbey D; Agbas A; Aksu B; Yildiz N; Uckardes D; Saygili S; Yilmaz EK; Yildirim ZY; Tasdemir M; Kiykim A; Cokugras H; Canpolat N; Nayir A; Kocazeybek B; Caliskan S
    Pediatr Nephrol; 2023 Jul; 38(7):2199-2208. PubMed ID: 36459243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and Effects of Vaccination on Sars-Cov-2 Omicron Infection in Kidney Transplant Recipients.
    Chiu HF; Tsai SF; Wu MJ; Yu TM; Chuang YW; Chen CH
    Transplant Proc; 2023 May; 55(4):820-823. PubMed ID: 37208223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of COVID-19 Vaccination With Risk of COVID-19 Infection, Hospitalization, and Death in Heart Transplant Recipients.
    Peters LL; Raymer DS; Pal JD; Ambardekar AV
    JAMA Cardiol; 2022 Jun; 7(6):651-654. PubMed ID: 35475896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus disease 2019 vaccine in pediatric post-kidney transplantation.
    Ajlan AA; Aleid H; Ali T; DeVol E; Marquez KAH; Aldhaferi R; Karar EM; Mohammed AEI; Tiba M; Fajji L; Aldakhil H; Al-Awwami M; Almslam MS; Assiri A; Algoufi T; Broering DC
    Clin Transplant; 2023 Jun; 37(6):e14983. PubMed ID: 37026809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-human leukocyte antigen and anti-ABO antibodies after SARS-CoV-2 mRNA vaccination in kidney transplant recipients.
    Nishida H; Takai S; Ito H; Fukuhara H; Nawano T; Narisawa T; Kanno H; Yagi M; Yamagishi A; Sakurai T; Naito S; Tsuchiya N
    Clin Transplant; 2023 May; 37(5):e14952. PubMed ID: 36846878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus variability is associated with de novo donor-specific antibody development in pediatric renal transplant recipients.
    Solomon S; Colovai A; Del Rio M; Hayde N
    Pediatr Nephrol; 2020 Feb; 35(2):261-270. PubMed ID: 31732803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morning administration enhances humoral response to SARS-CoV-2 vaccination in kidney transplant recipients.
    Zahradka I; Tichanek F; Magicova M; Modos I; Viklicky O; Petr V
    Am J Transplant; 2024 Sep; 24(9):1690-1697. PubMed ID: 38460787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course, management and outcomes of COVID-19 in HIV-infected renal transplant recipients: A case series.
    Bertels L; Manning K; Redd A; Du Toit T; Barday Z; Muller E
    S Afr Med J; 2024 Apr; 114(3b):e1374. PubMed ID: 39041439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.
    Biagio P; Rosa C; Nicola SM; Fabrizio S; Amerigo P; Giulia Z; Riccardo S; Riccardo V; Paolo R; Lorenzo S; Ivan G; Federico Ii Covid Team
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological Response to the BNT162b2 COVID-19 mRNA Vaccine in Adolescent and Young Adult Kidney Transplant Recipients.
    Haskin O; Ashkenazi-Hoffnung L; Ziv N; Borovitz Y; Dagan A; Levi S; Koren G; Hamdani G; Levi-Erez D; Landau D; Alfandary H
    Transplantation; 2021 Nov; 105(11):e226-e233. PubMed ID: 34381004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope Mapping of SARS-CoV-2 Spike Antibodies in Vaccinated Kidney Transplant Recipients Reveals Poor Spike Coverage Compared to Healthy Controls.
    Karaba AH; Morgenlander WR; Johnston TS; Hage C; Pekosz A; Durand CM; Segev DL; Robien MA; Heeger PS; Larsen CP; Blankson JN; Werbel WA; Larman HB; Tobian AAR
    J Infect Dis; 2024 May; 229(5):1366-1371. PubMed ID: 38019656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response to third SARS-CoV-2 vaccination in seronegative kidney transplant recipients: Possible improvement by mycophenolate mofetil reduction.
    Kantauskaite M; Müller L; Hillebrandt J; Lamberti J; Fischer S; Kolb T; Ivens K; Koch M; Andree M; Lübke N; Schmitz M; Luedde T; Orth HM; Feldt T; Schaal H; Adams O; Schmidt C; Kittel M; Königshausen E; Rump LC; Timm J; Stegbauer J
    Clin Transplant; 2022 Nov; 36(11):e14790. PubMed ID: 35997031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between SARS-CoV-2 Messenger RNA Vaccines and Lower Infection Rates in Kidney Transplant Recipients : A Registry-Based Report.
    Zahradka I; Petr V; Modos I; Magicova M; Dusek L; Viklicky O
    Ann Intern Med; 2022 Jul; 175(7):961-968. PubMed ID: 35500256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the influenza vaccine on pediatric kidney transplant outcomes.
    Camerino M; Jackson S; Chinnakotla S; Verghese P
    Pediatr Transplant; 2019 Mar; 23(2):e13354. PubMed ID: 30714274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.